Evidence map›Paper›PMID 29437626›Full record

ArticleAntimicrobial agents and chemotherapy2018

Compounds with Potential Activity against Mycobacterium tuberculosis.

C Sao Emani, M J Williams, I J Wiid, B Baker, C Carolis

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A reevaluation of iron binding by Mycobactin J.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2018
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

C Sao EmaniDST-NRF Centre of Excellence in Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, and Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa karallia@sun.ac.za brubaker@sun.ac.za Carlo.Carolis@crg.eu.
M J WilliamsDST-NRF Centre of Excellence in Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, and Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
I J WiidDST-NRF Centre of Excellence in Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, and Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
B Baker *DST-NRF Centre of Excellence in Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, and Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa karallia@sun.ac.za brubaker@sun.ac.za Carlo.Carolis@crg.eu.
C Carolis *Barcelona Biomedical Research Park, Centre for Genomic Regulation, Biomolecular Screening and Protein Technologies Unit, Barcelona, Spain karallia@sun.ac.za brubaker@sun.ac.za Carlo.Carolis@crg.eu.
Centre for Genomic Regulation · ESSouth African Medical Research Council · ZASouth African Tuberculosis Vaccine Initiative · ZAStellenbosch University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high acquisition rate of drug resistance by

Indexed as

Antitubercular AgentsAzaguanineMutationMycobacterium tuberculosisOxidative StressSulfaguanidineSulfhydryl CompoundsAntitubercular AgentsAzaguanineSulfaguanidineSulfhydryl Compoundsantimicrobial agentsoxidative stresssusceptibility testingthiols

Identifiers

PMID29437626
PMCPMC5913991
OpenAlexW2793103152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.